Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]pyridine Antileishmanial PharmacophoreRomain Paoli-Lombardo, Nicolas Primas, Sandra Bourgeade-Delmas, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 10, 2026
Fluorine Makes the Difference-Gold(I)-NHC Complexes With Fluoroaryl Substituents Exhibit Highly Potent Antileishmanial ActivitySoumia Ftouh, Sandra Bourgeade-Delmas, Chloé Salis, et al.
European Journal of Medicinal Chemistry|June 10, 2018
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR studyJulien Pedron, Clotilde Boudot, Sébastien Hutter, et al.
Journal of Lipid Research|January 11, 2019
Polyunsaturated fatty acid metabolites: biosynthesis in Leishmania and role in parasite/host interactionLucie Paloque, Teresa Perez-Berezo, Anne Abot, et al.
European Journal of Medicinal Chemistry|August 10, 2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductasesCyril Fersing, Clotilde Boudot, Julien Pedron, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial ActivityCyril Fersing, Louise Basmaciyan, Clotilde Boudot, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruziJulien Pedron, Clotilde Boudot, Jean-Yves Brossas, et al.
European Journal of Medicinal Chemistry|July 12, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruziCyril Fersing, Clotilde Boudot, Caroline Castera-Ducros, et al.
Pageof 3